Brian Mehling, M.D. – the Founder and Chief Medical Officer of Blue Horizon International (BHI), answers questions on Stem Cells in Regenerative Medicine (Episode 2)

Related posts

Paper from BHI Therapeutic Sciences and Blue Horizon International, Slovakia Published in the Journal of Clinical Medicine Research

by bluehorizon
5 years ago

Pavel Yufit, MD of Mehling Orthopedics Named NJ Top Doc For 2023

by bluehorizon
2 years ago

Blue Horizon International CEO Recognized by the International Nurses Association

by bluehorizon
5 years ago
Exit mobile version